DRKS00021752已完成不适用
Study platform ArcHIV - Substudy on SARS-CoV-2 (COVID-19) IgG antibody prevalence in an HIV cohort - ArcHIV - SARS-CoV-2 IgG
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patient is already a study participant in ArcHIV, the signed patient information with consent and privacy declaration for this substudy
排除标准
- •Patient is not a study participant of the study platform ArcHIV, patient <18 years, Patient has no present signed consent and privacy statement of the substudy
研究者
相似试验
尚未招募
不适用
: Serial sero-epidemiological surveillance study to monitor the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the Vellore Demographic Health Surveillance System (HDSS)CTRI/2020/12/029564Dr Winsley Rose
已完成
不适用
Collection of Anti-SARS-CoV-2 Immune PlasmaCoronavirus Disease 2019 (COVID-19)NCT04344977National Institute of Allergy and Infectious Diseases (NIAID)151
招募中
不适用
Observational study to assess the SARS-CoV-2 specific immune Response in patients with chronic kidney diseaseZ99.2U07.1Dependence on renal dialysisCOVID-19, virus identifiedDRKS00024632ierenzentrum Heidelberg80
尚未招募
不适用
Assessment of SARS CoV-2 seroprevalence and clinical profiling of COVID Unsuspected patients attending Otorhinolaryngology Department at AIIMS Jodhpur.CTRI/2020/10/028598All India Institute of Medical Sciences Jodhpur
已完成
不适用
Cross Sectional CFAR HIV/COVID-19 StudySARS-CoV InfectionCovid19NCT04514016University of Miami64